Register entry
- Registered sites
- 0
- Active NDC listings
- 46
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
4646 active NDC listings: 44 drug for further processing, 2 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 44, BULK INGREDIENT 2.
| Dosage form | NDCs |
|---|---|
| capsule | 16 |
| tablet, film coated | 13 |
| tablet | 8 |
| capsule, delayed release | 7 |
| crystal | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| lilly del caribe, inc. | 46 |
Catalogue
Marketed products
46| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Atomoxetine hydrochloride | capsule | 0110-3227DRUG FOR FURTHER PROCESSING |
| - | Atomoxetine hydrochloride | capsule | 0110-3228DRUG FOR FURTHER PROCESSING |
| - | Atomoxetine hydrochloride | capsule | 0110-3229DRUG FOR FURTHER PROCESSING |
| - | Atomoxetine hydrochloride | capsule | 0110-3238DRUG FOR FURTHER PROCESSING |
| - | Atomoxetine hydrochloride | capsule | 0110-3239DRUG FOR FURTHER PROCESSING |
| - | Atomoxetine hydrochloride | capsule | 0110-3250DRUG FOR FURTHER PROCESSING |
| - | Atomoxetine hydrochloride | capsule | 0110-3251DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-3235DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-3240DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-3270DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-9542DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-9543DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-9544DRUG FOR FURTHER PROCESSING |
| - | Duloxetine hydrochloride | capsule, delayed release | 0110-9545DRUG FOR FURTHER PROCESSING |
| - | Fluoxetine hydrochloride | capsule | 0110-3104DRUG FOR FURTHER PROCESSING |
| - | Fluoxetine hydrochloride | capsule | 0110-3105DRUG FOR FURTHER PROCESSING |
| - | Fluoxetine hydrochloride | capsule | 0110-3107DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | crystal | 0110-0541BULK INGREDIENT |
| - | Insulin lispro | crystal | 0110-0571BULK INGREDIENT |
| - | Raloxifene hydrochloride | tablet | 0110-4184DRUG FOR FURTHER PROCESSING |
| - | Tadalafil | tablet, film coated | 0110-4462DRUG FOR FURTHER PROCESSING |
| - | Tadalafil | tablet, film coated | 0110-4463DRUG FOR FURTHER PROCESSING |
| - | Tadalafil | tablet, film coated | 0110-4464DRUG FOR FURTHER PROCESSING |
| - | Tadalafil | tablet, film coated | 0110-4465DRUG FOR FURTHER PROCESSING |
| - | Tadalafil | tablet | 0110-4467DRUG FOR FURTHER PROCESSING |
| - | abemaciclib | tablet | 0110-4483DRUG FOR FURTHER PROCESSING |
| - | abemaciclib | tablet | 0110-4815DRUG FOR FURTHER PROCESSING |
| - | abemaciclib | tablet | 0110-5337DRUG FOR FURTHER PROCESSING |
| - | abemaciclib | tablet | 0110-6216DRUG FOR FURTHER PROCESSING |
| - | baricitinib | tablet, film coated | 0110-4182DRUG FOR FURTHER PROCESSING |
| - | baricitinib | tablet, film coated | 0110-4479DRUG FOR FURTHER PROCESSING |
| - | baricitinib | tablet, film coated | 0110-4732DRUG FOR FURTHER PROCESSING |
| - | lasmiditan | tablet | 0110-4312DRUG FOR FURTHER PROCESSING |
| - | lasmiditan | tablet | 0110-4491DRUG FOR FURTHER PROCESSING |
| - | orforglipron | capsule | 0110-0248DRUG FOR FURTHER PROCESSING |
| - | orforglipron | capsule | 0110-0700DRUG FOR FURTHER PROCESSING |
| - | orforglipron | capsule | 0110-1080DRUG FOR FURTHER PROCESSING |
| - | orforglipron | capsule | 0110-1230DRUG FOR FURTHER PROCESSING |
| - | orforglipron | capsule | 0110-1520DRUG FOR FURTHER PROCESSING |
| - | orforglipron | capsule | 0110-1625DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 0110-4178DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 0110-4503DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 0110-4794DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 0110-4803DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 0110-4839DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 0110-4953DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing orforglipron
- Eli Lilly and Company10 sites · 189 NDC
- Pfizer Italia S.r.l.0 sites · 9 NDC
Enquiry
Common questions
- Is Lilly del Caribe, Inc. FDA approved?
- Lilly del Caribe, Inc. holds no registered establishment of its own; 46 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Lilly del Caribe, Inc. make?
- 46 products are listed under Lilly del Caribe, Inc. in the openFDA NDC Directory, most often as capsule; tablet, film coated; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.